Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD).

Name: Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD).
Published: 2026
License: Public Domain

Institute of Hematology & Blood Diseases Hospital, China · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

cgvhd, hsct, gecacitinib, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD).

Related documents